Compounds > catechin

catechin and Multiple System Atrophy

catechin has been researched along with Multiple System Atrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stamelou, M1
Berg, D; Bötzel, K; Classen, J; Eberhardt, C; Egert-Schwender, S; Eggert, K; Ertl-Wagner, B; Gandor, F; Giese, A; Höglinger, GU; Huppertz, HJ; Kassubek, J; Levin, J; Lipp, A; Löhle, M; Maaß, S; Mansmann, U; Mollenhauer, B; Münchau, A; Oertel, WH; Paul, F; Poewe, W; Ricard, I; Schuberth, M; Südmeyer, M; Trenkwalder, C; Wenning, GK1
Bötzel, K; Giese, A; Höglinger, G; Krismer, F; Levin, J; Lorenzl, S; Maaß, S; Mansmann, U; Oertel, WH; Paul, F; Poewe, W; Respondek, G; Schuberth, M; Seppi, K; Wenning, G1

Trials

2 trial(s) available for catechin and Multiple System Atrophy

ArticleYear
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
    The Lancet. Neurology, 2019, Volume: 18, Issue:8

    Topics: Aged; Catechin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Male; Middle Aged; Multiple System Atrophy; Neuroprotective Agents; Treatment Outcome

2019
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
    Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:4

    Topics: Catechin; Disease Progression; Double-Blind Method; Humans; Multiple System Atrophy; Neuroprotective Agents; Research Design

2016

Other Studies

1 other study(ies) available for catechin and Multiple System Atrophy

ArticleYear
Neuroprotection in multiple system atrophy: unresolved issues.
    The Lancet. Neurology, 2019, Volume: 18, Issue:8

    Topics: Catechin; Double-Blind Method; Humans; Multiple System Atrophy; Neuroprotection

2019